L. Description-des, 25 2) L'apparition d'herpès, p.27

S. Agbo-godeau, E. Nicolas-virelizier, and F. Scotté, [Management of side effects of targeted therapies in renal cancer: stomatological side effects (mucositis, epistaxis)], Bull Cancer

R. Amato and M. Stepankiw, Evaluation of everolimus in renal cell cancer, Expert Opinion on Pharmacotherapy, vol.28, issue.5, p.122940, 2013.
DOI : 10.1164/rccm.200911-1720OC

L. Araujo, J. Lima, L. Alvarenga, T. Martelli-júnior, H. Coletta et al., Oral and neurocutaneous phenotypes of familial tuberous sclerosis, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.111, issue.1, p.8794, 2011.
DOI : 10.1016/j.tripleo.2010.07.002

L. Araújo, J. Muniz, G. Santos, E. Ladeia, J. Martelli et al., Tuberous sclerosis complex diagnosed from oral lesions, Sao Paulo Medical Journal, vol.131, issue.5, p.3515, 2013.
DOI : 10.1590/1516-3180.2013.1315441

H. Baskin, The pathogenesis and imaging of the tuberous sclerosis complex, Pediatric Radiology, vol.13, issue.9, p.93652, 2008.
DOI : 10.1007/s00247-008-0832-y

R. Bensadoun, L. Page, F. Darcourt, V. Bensadoun, F. Ciais et al., Radiation-induced mucositis of the aerodigestive tract: prevention and treatment. MASCC/ISOO mucositis group's recommendations], Bull Cancer, vol.93, issue.2, p.20111, 2006.

A. Bessard, Les thérapies ciblées inhibitrices de mTOR [Thèse d'exercice, 2013.

K. Ess, Tuberous sclerosis complex: everything old is new again, Journal of Neurodevelopmental Disorders, vol.105, issue.24, p.1419, 2009.
DOI : 10.1073/pnas.0712268105

W. Feng, X. Duan, J. Liu, X. J. Brown, and R. , Morphoproteomic evidence of constitutively activated and overexpressed mTOR pathway in cervical squamous carcinoma and high grade squamous intraepithelial lesions, Int J Clin Exp Pathol, vol.2, issue.3, p.24960, 2009.

J. Fricain, K. Cellerié, V. Sibaud, S. Catros, A. Taïeb et al., Oral ulcers in kidney allograft recipients treated with sirolimus], Ann Dermatol Vénéréologie. nov, vol.135, issue.11, p.73741, 2008.

M. Gomez, Tuberous Sclerosis, 1979.
DOI : 10.1016/B978-0-409-90018-7.50008-6

P. Jahagirdar, R. Eeraveni, S. Ponnuraj, and N. Kamarthi, Tuberous sclerosis: A novel approach to diagnosis, Journal of Indian Society of Pedodontics and Preventive Dentistry, vol.29, issue.6, p.525, 2011.
DOI : 10.4103/0970-4388.90742

M. Koga, I. Nakayama, T. Sakai, K. Koga, S. Imafuku et al., Disseminated herpes simplex virus type-1 infection in long-term usage of everolimus, The Journal of Dermatology, vol.35, issue.1, p.834, 2013.
DOI : 10.1111/j.1346-8138.2012.01674.x

D. Krueger and D. Franz, Current Management of Tuberous Sclerosis Complex, Pediatric Drugs, vol.146, issue.9, p.299313, 2008.
DOI : 10.2165/00148581-200810050-00004

D. Krueger and N. H. , International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference, Pediatr Neurol. oct, vol.49, issue.4, p.25565, 2013.

C. Mateus and C. Robert, Effets cutan??s des nouvelles mol??cules utilis??es en canc??rologie, La Revue de M??decine Interne, vol.30, issue.5, p.40110, 2009.
DOI : 10.1016/j.revmed.2009.02.001

R. Moavero, A. Coniglio, F. Garaci, and P. Curatolo, Is mTOR inhibition a systemic treatment for tuberous sclerosis?, Italian Journal of Pediatrics, vol.39, issue.1, p.57, 2013.
DOI : 10.1038/sj.clpt.6100317

C. Monatte, Rôle du papilloma virus humain (HPV) dans le développement des cancers des voies aéro-digestives supérieures (VADS) [Thèse d'exercice, 2011.

V. Narayanan, Tuberous sclerosis complex: genetics to pathogenesis, Pediatric Neurology, vol.29, issue.5, p.4049, 2003.
DOI : 10.1016/j.pediatrneurol.2003.09.002

O. Nicolatou-galitis, A. Nikolaidi, I. Athanassiadis, E. Papadopoulou, and S. Sonis, Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol.116, issue.2, p.1106, 2013.
DOI : 10.1016/j.oooo.2013.02.022

H. Northrup and D. Krueger, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference, Pediatr Neurol. oct, vol.49, issue.4, p.24354, 2013.

M. De-oliveira, E. Martins, F. Martins, Q. Wang, S. Sonis et al., Clinical presentation and management of mTOR inhibitor-associated stomatitis, Oral Oncology, vol.47, issue.10, p.9981003, 2011.
DOI : 10.1016/j.oraloncology.2011.08.009

S. Piaserico, E. Sandini, A. Peserico, and M. Alaibac, Cutaneous viral infections in organ transplant patients

A. Pilotte, M. Hohos, K. Polson, T. Huftalen, and N. Treister, Managing Stomatitis in Patients Treated With Mammalian Target of Rapamycin Inhibitors, Clinical Journal of Oncology Nursing, vol.15, issue.5, p.839, 2011.
DOI : 10.1188/11.CJON.E83-E89

J. Pindborg, Atlas des maladies de la muqueuse buccale, 1980.

B. Russell, M. Russell, F. Praetorius, and C. Russell, Deciduous teeth in tuberous sclerosis, Clinical Genetics, vol.7, issue.1, p.3640, 1996.
DOI : 10.1111/j.1399-0004.1996.tb02343.x

D. Seibert, C. Hong, F. Takeuchi, C. Olsen, O. Hathaway et al., Recognition of Tuberous Sclerosis in Adult Women: Delayed Presentation With Life-Threatening Consequences, Annals of Internal Medicine, vol.154, issue.12, p.806294, 2011.
DOI : 10.7326/0003-4819-154-12-201106210-00008

S. Sonis, A biological approach to mucositis, J Support Oncol. févr, vol.2, issue.356, p.2132, 2004.

N. Stollery, Oral and perioral lesions. The Practitioner, p.313, 1718.

J. Teng, E. Cowen, M. Wataya-kaneda, E. Gosnell, P. Witman et al., Dermatologic and Dental Aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements, JAMA Dermatology, vol.150, issue.10, p.1095101, 2014.
DOI : 10.1001/jamadermatol.2014.938

Y. Wang, Everolimus in renal cell carcinoma. Drugs Today Barc Spain, août, vol.46, issue.8, p.55766, 1998.

A. Watters, J. Epstein, and M. Agulnik, Oral complications of targeted cancer therapies: A narrative literature review, Oral Oncology, vol.47, issue.6, p.4418, 2011.
DOI : 10.1016/j.oraloncology.2011.03.028